Filing Details

Accession Number:
0001395064-24-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-25 06:13:10
Reporting Period:
2024-01-24
Accepted Time:
2024-01-25 06:13:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1783183 Phathom Pharmaceuticals Inc. PHAT Pharmaceutical Preparations (2834) 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1395064 Takeda Pharmaceutical Co Ltd 1-1, Nihonbashi-Honcho 2-Chome
Chuo-Ku, Tokyo M0 103-8668
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-24 3,703,703 $8.10 3,755,583 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct